Wind tunnel investigation of the aerodynamic characteristics of five forebody models at high angles of attack at Mach numbers from 0.25 to 2

Five forebody models of various shapes were tested in the Ames 6- by 6-Foot Wind Tunnel to determine the aerodynamic characteristics at Mach numbers from 0.25 to 2 at a Reynolds number of 800000. At a Mach number of 0.6 the Reynolds number was varied from 0.4 to 1.8 mil. Angle of attack was varied from -2 deg to 88 deg at zero sideslip. The purpose of the investigation was to determine the effect of Mach number of the side force that develops at low speeds and zero sideslip for all of these forebody models when the nose is pointed. Test results show that with increasing Mach number the maximum side forces decrease to zero between Mach numbers of 0.8 and 1.5, depending on the nose angle; the smaller the nose angle of the higher the Mach number at which the side force exists. At a Mach number of 0.6 there is some variation of side force with Reynolds number, the variation being the largest for the more slender tangent ogive

Side forces on a tangent ogive forebody with a fineness ratio of 3.5 at high angles of attack and Mach numbers from 0.1 to 0.7

An experimental investigation was conducted in the Ames 12-Foot Wind Tunnel to determine the subsonic aerodynamic characteristics, at high angles of attack, of a tangent ogive forebody with a fineness ratio of 3.5. The investigation included the effects of nose bluntness, nose strakes, nose booms, a simulated canopy, and boundary-layer trips. The forebody was also tested with a short afterbody attached. Static longitudinal and lateral-directional stability data were obtained at Reynolds numbers ranging from 0.3 mil. to 3.8 mil. (based on base diameter) at a Mach number of 0.25, and at a Reynolds number of 0.8 mil. at Mach numbers ranging from 0.1 to 0.7. Angle of attack was varied from 0 to 88 deg at zero sideslip, and the sideslip angle was varied from -10 to 30 deg at angles of attack of 40, 55, and 70 deg

Side forces on forebodies at high angles of attack and Mach numbers from 0.1 to 0.7: two tangent ogives, paraboloid and cone

An experimental investigation was conducted in the Ames 12-Foot Wind Tunnel to determine the subsonic aerodynamic characteristics of four forebodies at high angles of attack. The forebodies tested were a tangent ogive with fineness ratio of 5, a paraboloid with fineness ratio of 3.5, a 20 deg cone, and a tangent ogive with an elliptic cross section. The investigation included the effects of nose bluntness and boundary-layer trips. The tangent-ogive forebody was also tested in the presence of a short afterbody and with the afterbody attached. Static longitudinal and lateral/directional stability data were obtained. The investigation was conducted to investigate the existence of large side forces and yawing moments at high angles of attack and zero sideslip. It was found that all of the forebodies experience steady side forces that start at angles of attack of from 20 deg to 35 deg and exist to as high as 80 deg, depending on forebody shape. The side is as large as 1.6 times the normal force and is generally repeatable with increasing and decreasing angle of attack and, also, from test to test. The side force is very sensitive to the nature of the boundary layer, as indicated by large changes with boundary trips. The maximum side force caries considerably with Reynolds number and tends to decrease with increasing Mach number. The direction of the side force is sensitive to the body geometry near the nose. The angle of attack of onset of side force is not strongly influenced by Reynolds number or Mach number but varies with forebody shape. Maximum normal force often occurs at angles of attack near 60 deg. The effect of the elliptic cross section is to reduce the angle of onset by about 10 deg compared to that of an equivalent circular forebody with the same fineness ratio. The short afterbody reduces the angle of onset by about 5 deg

20 Meter Solar Sail Analysis and Correlation

This presentation discusses studies conducted to determine the element type and size that best represents a 20-meter solar sail under ground-test load conditions, the performance of test/Analysis correlation by using Static Shape Optimization Method for Q4 sail, and system dynamic. TRIA3 elements better represent wrinkle patterns than do QUAD3 elements Baseline, ten-inch elements are small enough to accurately represent sail shape, and baseline TRIA3 mesh requires a reasonable computation time of 8 min. 21 sec. In the test/analysis correlation by using Static shape optimization method for Q4 sail, ten parameters were chosen and varied during optimization. 300 sail models were created with random parameters. A response surfaces for each targets which were created based on the varied parameters. Parameters were optimized based on response surface. Deflection shape comparison for 0 and 22.5 degrees yielded a 4.3% and 2.1% error respectively. For the system dynamic study testing was done on the booms without the sails attached. The nominal boom properties produced a good correlation to test data the frequencies were within 10%. Boom dominated analysis frequencies and modes compared well with the test results

Blood Group Distribution in Switzerland - a Historical Comparison.

BACKGROUND Ethnicities differ in prevalence of blood groups and antigens. Substantial donor-recipient mismatch within mixed-ethnic societies may render certain recipients at higher risk for alloimmunization. Data regarding antigen distribution within Switzerland by ethnicity is limited. We examined immigration patterns against the distribution of ABO blood groups using large cross-sectional Swiss samples spanning 70 years. METHODS Historical ABO blood group distribution data (1940-1945) from Swiss army personnel (n = 275,664) were sourced from the literature. Recent blood group phenotypes of 122,925 individuals who presented themselves at army recruitment centers (2004-2015) were obtained, alongside a validation sample of 175,202 patients from a university hospital. Two-sample tests with z-statistics assessing blood groups between samples were used. RESULTS The respective proportions of A (47.2% and 45.2%), B (8.4% and 9.8%), and AB (3.0 and 4.1) in the historical and recent army samples were significantly different (p < 0.001), while group O was not. Conclusion: ABO blood groups in Switzerland have remained stable despite substantial immigration with a changing foreign-national profile. Further research is needed to improve the understanding of antigen differences in newly introduced ethnic groups. Blood product requirements and public health initiatives aimed at recruiting blood donors would benefit from this information

Hemolytic uremic syndrome following the infusion of oxaliplatin: case report

BACKGROUND: Oxaliplatin is a platinum derivative, which is used in the treatment of colorectal cancer. A small number of oxaliplatin-related hemolytic and/or thrombocytopenic reactions have been reported. We present a case of hemolytic-uremic syndrome that developed during the 4(th )cycle of combination chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin. CASE PRESENTATION: A 52-year-old-male was administered chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin for a Duke's stage C colorectal carcinoma. Three cycles of chemotherapy had been administered without complications when, at the beginning of the fourth cycle, the patient developed clinical and laboratory abnormalities consistent with the development of the hemolytic-uremic syndrome. Treatment was discontinued; the patient was managed with monitored IV hydration and loop diuretics, high dose corticosteroids and fresh frozen plasma infusions and recovered completely. CONCLUSION: The hemolytic-uremic syndrome may be a rare complication of oxaliplatin-based chemotherapy. Clinicians need to maintain a high index of suspicion to diagnose and treat this life-threatening adverse event

Bioclimatic Architecture and Urban Morphology. Studies on Intermediate Urban Open Spaces

This paper deals with the interactions between biophysical and microclimatic factors on the one hand with, on the other, the urban morphology of intermediate urban open spaces, the relationship between environmental and bioclimatic thermal comfort, and the implementation of innovative materials and the use of greenery, aimed at the users’ well-being. In particular, the thermal comfort of the open spaces of the consolidated fabrics of the city of Rome is studied, by carrying out simulations of cooling strategies relating to two scenarios applied to Piazza Bainsizza. The first scenario involves the use of cool materials for roofs, cladding surfaces, and pavement, while the second scenario, in addition to the cool materials employed in the first scenario, also includes the use of greenery and permeable green surfaces. The research was performed using summer and winter microclimatic simulations of the CFD (ENVI-met v. 3.1) type, in order to determine the dierent influences of the materials with cold colors, trees, and vegetated surfaces on the thermal comfort of the urban morphology itself. Meanwhile, the comfort assessment was determined through the physiological equivalent temperature (PET) calculated with the RayMan program. The first scenario, with the use of cool materials, improves summer conditions and reduces the urban heat island eect but does not eliminate thermal discomfort due to the lack of shaded surfaces and vegetation. The second scenario, where material renovations is matched with vegetation improvements, has a slightly bad eect on winter conditions but drastically ameliorates the summer situation, both for direct users and, thanks to the strong reduction of the urban heat island eect, to urban inhabitants as a whole

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study

This phase II study assessed the safety and efficacy of oxaliplatin and capecitabine in patients with advanced oesophageal cancer. Fifty-one eligible patients received oxaliplatin 130 mg m−2 intravenously on day 1 and capecitabine 1000 mg m−2 orally twice daily on days 1 to 14 in a 21-day treatment cycle as first-line treatment for advanced oesophageal cancer. Grade 3 neutropenia was seen in one patient and anaemia in another patient. No grade 4 haematological toxicities were observed. Grade 4 non-haematological toxicity (lethargy) occurred in one patient (2%). Grade 3 non-haematological toxicity was seen in 14 (27%) patients (vomiting and polyneuropathy (8%); nausea (6%); lethargy and hand–foot syndrome (4%); and anorexia, diarrhoea, and hyperbilirubinaemia (each in one patient)). In 22% of the patients, toxicity was the reason for stopping the treatment. The overall response rate was 39%. The median overall survival was 8 months; the 1-year survival rate was 26%. In the quality of life (QoL) analysis, the emotional well-being improved during treatment, but the physical functioning scores declined. The fatigue score on the symptom scales increased. Overall, the global QoL score did not change during treatment. In conclusion, the activity of oxaliplatin and capecitabine is comparable with other chemotherapy regimens in advanced oesophageal cancer with a low frequency of grade 3/4 toxicity. Because this treatment can be given on an outpatient basis, it is probably less toxic than cisplatin-based therapy and preserves QoL during treatment, it is a viable treatment option in patients with advanced oesophageal cancer